Optimization of intrabone delivery of hematopoietic progenitor cells in a swine model using cell radiolabeling with [89]zirconium

Jeremy Mark Pantin, R. F. Hoyt, O. Aras, N. Sato, M. Y. Chen, T. Hunt, R. Clevenger, P. Eclarinal, S. Adler, P. Choyke, Richard W. Childs

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Intrabone (IB) hematopoietic cell transplantation (HCT) of umbilical cord blood in humans remains experimental and the technique has not been optimized. It is unknown whether hematopoietic progenitor cells (HPCs) injected IB are initially retained in the marrow or rapidly enter into the venous circulation before homing to the marrow. To develop an IB-injection technique that maximizes HPC marrow-retention, we tracked radiolabeled human HPCs following IB-injection into swine. We developed a method to radionuclide-label HPCs using a long-lived positron emitter 89Zr and protamine sulfate that resulted in cellular-retention of low-dose radioactivity. This approach achieved radioactivity levels sufficient for detection by positron emission tomography with both high sensitivity and spatial resolution when fused with computed tomography. We found that conditions utilized in pilot IB-HCT clinical trials conducted by others led to both rapid drainage into the central venous circulation and cellular extravasation into surrounding muscle and soft tissues. By optimizing the needle design, using continuous real-time intra-marrow pressure monitoring, and by reducing the infusion-volume and infusion-rate, we overcame this limitation and achieved high retention of HPCs in the marrow. This method of IB cellular delivery is readily applicable in the clinic and could be utilized in future investigational IB-HCT trials aimed at maximizing marrow retention of HPCs.

Original languageEnglish (US)
Pages (from-to)606-617
Number of pages12
JournalAmerican Journal of Transplantation
Volume15
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Hematopoietic Stem Cells
Swine
Bone Marrow
Cell Transplantation
Radioactivity
Injections
Protamines
Fetal Blood
Radioisotopes
Positron-Emission Tomography
Needles
Drainage
Tomography
Clinical Trials
Electrons
Pressure
Muscles

Keywords

  • animal models: porcine
  • basic (laboratory) research/science
  • bone marrow
  • clinical research/practice
  • diagnostic techniques and imaging: positron emission tomography
  • graft survival
  • graft-versus-host disease (GVHD)
  • hematology/oncology
  • hematopoietic stem cell transplantation
  • monitoring: physiologic
  • xenotransplantation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Optimization of intrabone delivery of hematopoietic progenitor cells in a swine model using cell radiolabeling with [89]zirconium. / Pantin, Jeremy Mark; Hoyt, R. F.; Aras, O.; Sato, N.; Chen, M. Y.; Hunt, T.; Clevenger, R.; Eclarinal, P.; Adler, S.; Choyke, P.; Childs, Richard W.

In: American Journal of Transplantation, Vol. 15, No. 3, 01.03.2015, p. 606-617.

Research output: Contribution to journalArticle

Pantin, JM, Hoyt, RF, Aras, O, Sato, N, Chen, MY, Hunt, T, Clevenger, R, Eclarinal, P, Adler, S, Choyke, P & Childs, RW 2015, 'Optimization of intrabone delivery of hematopoietic progenitor cells in a swine model using cell radiolabeling with [89]zirconium', American Journal of Transplantation, vol. 15, no. 3, pp. 606-617. https://doi.org/10.1111/ajt.13007
Pantin, Jeremy Mark ; Hoyt, R. F. ; Aras, O. ; Sato, N. ; Chen, M. Y. ; Hunt, T. ; Clevenger, R. ; Eclarinal, P. ; Adler, S. ; Choyke, P. ; Childs, Richard W. / Optimization of intrabone delivery of hematopoietic progenitor cells in a swine model using cell radiolabeling with [89]zirconium. In: American Journal of Transplantation. 2015 ; Vol. 15, No. 3. pp. 606-617.
@article{8cb4a11a680143ac903f509b178776bb,
title = "Optimization of intrabone delivery of hematopoietic progenitor cells in a swine model using cell radiolabeling with [89]zirconium",
abstract = "Intrabone (IB) hematopoietic cell transplantation (HCT) of umbilical cord blood in humans remains experimental and the technique has not been optimized. It is unknown whether hematopoietic progenitor cells (HPCs) injected IB are initially retained in the marrow or rapidly enter into the venous circulation before homing to the marrow. To develop an IB-injection technique that maximizes HPC marrow-retention, we tracked radiolabeled human HPCs following IB-injection into swine. We developed a method to radionuclide-label HPCs using a long-lived positron emitter 89Zr and protamine sulfate that resulted in cellular-retention of low-dose radioactivity. This approach achieved radioactivity levels sufficient for detection by positron emission tomography with both high sensitivity and spatial resolution when fused with computed tomography. We found that conditions utilized in pilot IB-HCT clinical trials conducted by others led to both rapid drainage into the central venous circulation and cellular extravasation into surrounding muscle and soft tissues. By optimizing the needle design, using continuous real-time intra-marrow pressure monitoring, and by reducing the infusion-volume and infusion-rate, we overcame this limitation and achieved high retention of HPCs in the marrow. This method of IB cellular delivery is readily applicable in the clinic and could be utilized in future investigational IB-HCT trials aimed at maximizing marrow retention of HPCs.",
keywords = "animal models: porcine, basic (laboratory) research/science, bone marrow, clinical research/practice, diagnostic techniques and imaging: positron emission tomography, graft survival, graft-versus-host disease (GVHD), hematology/oncology, hematopoietic stem cell transplantation, monitoring: physiologic, xenotransplantation",
author = "Pantin, {Jeremy Mark} and Hoyt, {R. F.} and O. Aras and N. Sato and Chen, {M. Y.} and T. Hunt and R. Clevenger and P. Eclarinal and S. Adler and P. Choyke and Childs, {Richard W.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1111/ajt.13007",
language = "English (US)",
volume = "15",
pages = "606--617",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Optimization of intrabone delivery of hematopoietic progenitor cells in a swine model using cell radiolabeling with [89]zirconium

AU - Pantin, Jeremy Mark

AU - Hoyt, R. F.

AU - Aras, O.

AU - Sato, N.

AU - Chen, M. Y.

AU - Hunt, T.

AU - Clevenger, R.

AU - Eclarinal, P.

AU - Adler, S.

AU - Choyke, P.

AU - Childs, Richard W.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Intrabone (IB) hematopoietic cell transplantation (HCT) of umbilical cord blood in humans remains experimental and the technique has not been optimized. It is unknown whether hematopoietic progenitor cells (HPCs) injected IB are initially retained in the marrow or rapidly enter into the venous circulation before homing to the marrow. To develop an IB-injection technique that maximizes HPC marrow-retention, we tracked radiolabeled human HPCs following IB-injection into swine. We developed a method to radionuclide-label HPCs using a long-lived positron emitter 89Zr and protamine sulfate that resulted in cellular-retention of low-dose radioactivity. This approach achieved radioactivity levels sufficient for detection by positron emission tomography with both high sensitivity and spatial resolution when fused with computed tomography. We found that conditions utilized in pilot IB-HCT clinical trials conducted by others led to both rapid drainage into the central venous circulation and cellular extravasation into surrounding muscle and soft tissues. By optimizing the needle design, using continuous real-time intra-marrow pressure monitoring, and by reducing the infusion-volume and infusion-rate, we overcame this limitation and achieved high retention of HPCs in the marrow. This method of IB cellular delivery is readily applicable in the clinic and could be utilized in future investigational IB-HCT trials aimed at maximizing marrow retention of HPCs.

AB - Intrabone (IB) hematopoietic cell transplantation (HCT) of umbilical cord blood in humans remains experimental and the technique has not been optimized. It is unknown whether hematopoietic progenitor cells (HPCs) injected IB are initially retained in the marrow or rapidly enter into the venous circulation before homing to the marrow. To develop an IB-injection technique that maximizes HPC marrow-retention, we tracked radiolabeled human HPCs following IB-injection into swine. We developed a method to radionuclide-label HPCs using a long-lived positron emitter 89Zr and protamine sulfate that resulted in cellular-retention of low-dose radioactivity. This approach achieved radioactivity levels sufficient for detection by positron emission tomography with both high sensitivity and spatial resolution when fused with computed tomography. We found that conditions utilized in pilot IB-HCT clinical trials conducted by others led to both rapid drainage into the central venous circulation and cellular extravasation into surrounding muscle and soft tissues. By optimizing the needle design, using continuous real-time intra-marrow pressure monitoring, and by reducing the infusion-volume and infusion-rate, we overcame this limitation and achieved high retention of HPCs in the marrow. This method of IB cellular delivery is readily applicable in the clinic and could be utilized in future investigational IB-HCT trials aimed at maximizing marrow retention of HPCs.

KW - animal models: porcine

KW - basic (laboratory) research/science

KW - bone marrow

KW - clinical research/practice

KW - diagnostic techniques and imaging: positron emission tomography

KW - graft survival

KW - graft-versus-host disease (GVHD)

KW - hematology/oncology

KW - hematopoietic stem cell transplantation

KW - monitoring: physiologic

KW - xenotransplantation

UR - http://www.scopus.com/inward/record.url?scp=84923302951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923302951&partnerID=8YFLogxK

U2 - 10.1111/ajt.13007

DO - 10.1111/ajt.13007

M3 - Article

C2 - 25656824

AN - SCOPUS:84923302951

VL - 15

SP - 606

EP - 617

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 3

ER -